摘要
目的探讨普贝生配合缩宫素用于足月妊娠引产的临床效果及安全性。方法将120例妊娠足月、有引产指征的初产妇随机分为两组,研究组80例以普贝生并酌情配合缩宫素引产,对照组40例以缩宫素引产,比较两组产妇用药前后的宫颈Bishop评分、临产情况、剖宫产率、对母婴的影响。结果研究组促宫颈成熟有效率93.75%,高于对照组(40.00%),用药至临产时间(12.51±10.73)h,短于对照组(21.12±15.10)h,引产成功率高(97.50%),剖宫产率低(32.50%)。结论普贝生配合缩宫素可有效、安全地用于足月妊娠引产。
Objective To observe the clinical effects and safety of propess assisted oxytocin used for induction of term pregnancy.Methods 120 single term pregnant women without any vaginal delivery taboo were randomly divided into two group：80 cases in propess assisted oxytocin group,40 cases in oxytocin group.The cervical maturity（by Bishop scoring） before and after treatment、 the time to labor starting、Cesarean section rate、mother and neonatal condition were compared between two groups.Results Bishop score was increased≥2points in 93.75% cases in study group,whereas only 40.00 % cases in control group.The time to labor starting was shortned obviously in study group[（12.51±10.73）hours]than that in control group[（21.12±15.10）hours].Induced labor access rate was increased in the study group（97.50%）.Cesarean section rate was reduced in the study group（32.50%）.Conclusion Propess assisted oxytocin can be used for induction of term pregnancy effectively and safely.
出处
《中国妇产科临床杂志》
2008年第6期431-432,436,共3页
Chinese Journal of Clinical Obstetrics and Gynecology
关键词
普贝生
引产
足月妊娠
propess
induced labor
term pregnancy
